Polina Mikhryakova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Polina Mikhryakova has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Anastasia Khokhlova
Department of Biomedical Engineering, Washington University in St. Louis, St. Louis, MO, USA
1 shared publication - Daniil V. Shchepkin
Institute of Immunology and Physiology, Ural Branch of the Russian Academy of Sciences, Yekaterinburg 620049, Russia
1 shared publication - Raisa Simonova
Institute of Immunology and Physiology, Russian Academy of Sciences, Pervomayskaya Str. 106, 620078 Yekaterinburg, Russia
1 shared publication - Tatiana Myachina
Institute of Immunology and Physiology, Russian Academy of Sciences, Pervomajskaya Str. 106, 620049 Yekaterinburg, Russia
1 shared publication - Xenia A. Butova
Institute of Immunology and Physiology of the Ural Branch of the Russian Academy of Science, Pervomajskaya St. 106, Yekaterinburg 620078, Russia
1 shared publication
Latest Publications
- Open Access
- 17 May 2025
- Published by MDPI AG in Biomolecules
- Vol. 15 (5) , 735
An Exogenous NO Donor Provokes Mechanical Alternans in Normal Rat Atria and Impairs Sarcomere Contractility in Right Atrial Cardiomyocytes in Atrial Fibrillation
Atrial fibrillation (AF) is the most common arrhythmia worldwide. AF is associated with a deficiency in nitric oxide (NO) production, which contributes to disturbances in the electrical and mechanical function of the atrial myocardium. NO donors are considered promising for the treatment and prevention of AF, but their effects on atrial contractility are unclear. This study examines the direct impact of a low-molecular-weight NO donor, spermine-NONOate (NOC-22), on the contractile function of atrial cardiomyocytes in paroxysmal AF. To study whether an NO donor-induced increase in NO level causes chamber-specific changes in atrial contractility, we measured sarcomere length (SL) dynamics in contracting single cardiomyocytes from the rat left and right atria (LA, RA) using a 7-day acetylcholine-CaCl2-induced AF model. We showed that in control rats NOC-22 provoked alternans of sarcomere shortening in both LA and RA cardiomyocytes. In AF, NOC-22 decreased the sarcomere-shortening amplitudes and velocities of sarcomere shortening–relengthening and increased the magnitude of sarcomere-shortening alternans only in RA cardiomyocytes. The negative effects of NO donors on RA contractility warrant careful consideration of their use in AF treatment.
- 17 May 2025
- Published by MDPI AG in Biomolecules
- Vol. 15 (5) , 735
Open AccessAn Exogenous NO Donor Provokes Mechanical Alternans in Normal Rat Atria and Impairs Sarcomere Contractility in Right Atrial Cardiomyocytes in Atrial Fibrillation
Atrial fibrillation (AF) is the most common arrhythmia worldwide. AF is associated with a deficiency in nitric oxide (NO) production, which contributes to disturbances in the electrical and mechanical function of the atrial myocardium. NO donors are considered promising for the treatment and prevention of AF, but their effects on atrial contractility are unclear. This study examines the direct impact of a low-molecular-weight NO donor, spermine-NONOate (NOC-22), on the contractile function of atrial cardiomyocytes in paroxysmal AF. To study whether an NO donor-induced increase in NO level causes chamber-specific changes in atrial contractility, we measured sarcomere length (SL) dynamics in contracting single cardiomyocytes from the rat left and right atria (LA, RA) using a 7-day acetylcholine-CaCl2-induced AF model. We showed that in control rats NOC-22 provoked alternans of sarcomere shortening in both LA and RA cardiomyocytes. In AF, NOC-22 decreased the sarcomere-shortening amplitudes and velocities of sarcomere shortening–relengthening and increased the magnitude of sarcomere-shortening alternans only in RA cardiomyocytes. The negative effects of NO donors on RA contractility warrant careful consideration of their use in AF treatment.